Aarti Pharmalabs Share Price

Aarti Pharmalabs Limited is engaged in the manufacturing of active pharmaceutical ingredients (APIs), advanced intermediates, and xanthine derivatives, based in India. The Company also offers comprehensive contract development and manufacturing organization (CDMO) and CMO services for drug substances and new chemical entities (NCE), including their key starting materials (KSM) and regulatory starting materials (RSM), serving various pharmaceutical companies worldwide with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of HPAPIs, corticosteroids, cytotoxic medicines, and oncology products. Its caffeine products include caffeine anhydrous, and caffeine anhydrous (granules). Its range of API products include Ramipril, Quinapril HCL, Budesonide, Bambuterol HCL, Apixaban, Rivaroxaban, Cinacalcet and others. Its products are exported to key regulated markets such as the United States (US), the European Union, and Japan. As of 9 Jun 2026, Aarti Pharmalabs share price is ₹618.70. The stock opened at ₹609.05, compared to its previous close of ₹606.35. During today's trading session, Aarti Pharmalabs share price moved in the range of ₹607.00 to ₹622.50, with an average price of ₹614.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹607.00 and a high of ₹622.50. On the performance front, Aarti Pharmalabs share price has declined by 13.04% over the last six months and is down 33.31% on a year-on-year basis.

The market capitalization of Aarti Pharmalabs is ₹5,494 Crs, with a P/E ratio of 31.4 and a dividend yield of 0.58%.